These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6133286)

  • 1. Renal vasodilation by a prostaglandin analog during dopaminergic and alpha-adrenergic blockade.
    Seymour AA; Blaine EH
    Prostaglandins Leukot Med; 1983 Mar; 10(3):349-60. PubMed ID: 6133286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of some renal and cardiovascular effects of a prostaglandin analog, SKF 82526 and ibopamine in anesthetized dogs.
    Seymour AA; Blaine EH
    Arch Int Pharmacodyn Ther; 1984 Jun; 269(2):304-15. PubMed ID: 6148046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dopamine and blockade of dopaminergic and adrenergic receptors on coronary blood flow in ischemic rabbit myocardium.
    Rosolowsky M; Weiss HR
    J Cardiovasc Pharmacol; 1985; 7(4):700-8. PubMed ID: 2410711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of bulbocapnine as a peripheral dopamine receptor antagonists in the anesthetized cat.
    Pendleton RG; Finlay E; Sherman S
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 289(2):171-8. PubMed ID: 241025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and renal hemodynamic effects of intravenous infusions of the selective DA1 agonist, fenoldopam, used alone or in combination with dopamine and dobutamine.
    Lass NA; Glock D; Goldberg LI
    Circulation; 1988 Nov; 78(5 Pt 1):1310-5. PubMed ID: 2902941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoregulatory vasodilation enhances renal prostaglandin E2 and associated renin release during arachidonic acid infusion in dogs.
    Vikse A; Sejersted OM; Kiil F
    J Pharmacol Exp Ther; 1985 Jul; 234(1):261-6. PubMed ID: 3925129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal vasodilation with ureteral occlusion and prostaglandins: attenuation by histamine H1 antagonists.
    Banks RO; Jacobson ED
    Am J Physiol; 1985 Dec; 249(6 Pt 2):F851-7. PubMed ID: 2866716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of alpha-agonist on renin and prostaglandin E2 release in anesthetized dogs.
    Takahashi K; Hisa H; Satoh S
    Am J Physiol; 1984 Nov; 247(5 Pt 1):E604-8. PubMed ID: 6149693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of responses to dopamine in the mesenteric vascular bed of the cat.
    Lippton HL; Meyer RL; Parey SE; Hyman AL; Kadowitz PJ
    Arch Int Pharmacodyn Ther; 1981 May; 251(1):136-49. PubMed ID: 6114715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation by prostaglandins of the renal vascular action of arginine vasopressin.
    Oliver JA; Sciacca RR; Le Cren G; Cannon PJ
    Prostaglandins; 1982 Nov; 24(5):641-56. PubMed ID: 6962466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II and renal prostaglandin release in the dog. Interactions in controlling renal blood flow and glomerular filtration rate.
    Bugge JF; Stokke ES
    Acta Physiol Scand; 1994 Apr; 150(4):431-40. PubMed ID: 8036911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic conditions for renal PGE2 and renin release during alpha- and beta-adrenergic stimulation in dogs.
    Vikse A; Holdaas H; Sejersted OM; Kiil F
    Acta Physiol Scand; 1985 Jun; 124(2):163-72. PubMed ID: 2861715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Nitric oxide in the renal and systemic vasodilatory responses to platelet-activating factor in the rat, in vivo.
    Handa RK; Strandhoy JW; Handa SE
    Kidney Blood Press Res; 2003; 26(3):165-75. PubMed ID: 12886044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of renal prostaglandin in renin release during renal nerve stimulation in anesthetized dogs.
    Hisa H; Satoh S
    Arch Int Pharmacodyn Ther; 1983 Jan; 261(1):133-46. PubMed ID: 6342558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of long-term intrarenal angiotensin II infusion on renal vascular responsiveness to vasoactive agents.
    Fitzgerald SM; Stevenson KM; Evans RG; Anderson WP
    Clin Exp Pharmacol Physiol; 1998; 25(7-8):633-6. PubMed ID: 9673443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandins participate in the renal vasodilation due to hydralazine in dogs.
    Panzenbeck M; Baez A; Kaley G
    J Pharmacol Exp Ther; 1986 May; 237(2):525-8. PubMed ID: 3084759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal hemodynamics and natriuresis induced by the dopamine-1 agonist, SKF 82526.
    Jose PA; Eisner GM; Robillard JE
    Am J Med Sci; 1987 Sep; 294(3):181-6. PubMed ID: 2889360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of effects of adrenaline, dobutamine and dopamine on systemic hemodynamics and renal blood flow in patients following open heart surgery.
    Sato Y; Matsuzawa H; Eguchi S
    Jpn Circ J; 1982 Oct; 46(10):1059-72. PubMed ID: 7120650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of haloperidol on dopamine-induced increase in renal blood flow.
    Armstrong DK; Dasta JF; Reilley TE; Tallman RD
    Drug Intell Clin Pharm; 1986; 20(7-8):543-6. PubMed ID: 3743409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog.
    Nichols AJ; Smith JM; Shebuski RJ; Ruffolo RR
    J Pharmacol Exp Ther; 1987 Aug; 242(2):573-8. PubMed ID: 2886644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.